en
Scientific article
English

Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer's disease

Published inEuropean Journal of Nuclear Medicine and Molecular Imaging, vol. 47, no. 2, p. 270-280
Publication date2020
Abstract

PURPOSE: To compare the incremental diagnostic value of amyloid-PET and CSF (Aβ42, tau, and phospho-tau) in AD diagnosis in patients with mild cognitive impairment (MCI) or mild dementia, in order to improve the definition of diagnostic algorithm.

Keywords
  • Alzheimer's disease
  • Cerebrospinal fluid
  • Incremental diagnostic value
  • Mild cognitive impairment
  • Positron emission tomography
Citation (ISO format)
RAMUSINO, Matteo Cotta et al. Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease. In: European Journal of Nuclear Medicine and Molecular Imaging, 2020, vol. 47, n° 2, p. 270–280. doi: 10.1007/s00259-019-04466-6
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1619-7070
333views
6downloads

Technical informations

Creation10/25/2019 4:35:00 PM
First validation10/25/2019 4:35:00 PM
Update time03/15/2023 9:18:48 PM
Status update03/15/2023 9:18:46 PM
Last indexation05/05/2024 4:35:53 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack